Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.

The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.

Understand the key factors influencing breast cancer recurrence and discover effective treatments and lifestyle changes that lower your risk.

Ductal carcinoma in situ (DCIS) is a non-invasive breast condition found in nearly 20% of breast cancer diagnoses, but a growing number of doctors and medical experts are questioning whether the term ...

Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...

There is still time to complete key health screenings before the end of the year, and Check Up 13 is making it easier than ever.

Novel multi-omic biosignature for identification of early-stage invasive breast cancer patients who do and do not benefit from adjuvant radiation treatment after breast conservation surgery. This is ...

Please provide your email address to receive an email when new articles are posted on . Lobular breast cancer would be the seventh most common malignancy among women in the U.S. if ranked separately ...

Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly ...